Skip to content

Vascular Risk After Kidney Transplantation

Vascular Risk After Kidney Transplantation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00374595
Enrollment
338
Registered
2006-09-11
Start date
2006-04-30
Completion date
2023-06-20
Last updated
2023-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Chronic Kidney Disease, Diabetes, Hyperparathyroidism, Vitamin D Deficiency

Keywords

Kidney Transplant, Vascular Risk, inflammation, Diabetes, Insulin resistance, Chronic kidney disease

Brief summary

Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant. The purpose of this study is to evaluate which traditional and nontraditional cardiovascular disease risk factors best predict progression of cardiovascular disease (CVD) using carotid intima media thickness performed by ultrasound, in kidney transplant patients.

Detailed description

Cardiovascular disease remains the greatest cause of mortality after kidney transplant. Traditional risk factors, such as hypertension, diabetes, hyperlipidemia and smoking, contribute to vascular disease after transplant, but nontraditional risk factors may play a bigger role in vascular disease progression in this setting. This observational study will evaluate nontraditional risk factors for their contributions to vascular disease progression as determined by carotid intima media thickness and history of vascular disease events over time. The study requires annual checks of blood, urine, history, and carotid ultrasound for carotid intima media thickness

Interventions

None listed

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Nebraska
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Kidney transplant more than 6 months ago * 19 years or older

Exclusion criteria

* Estimated GFR \<30 * Previous small bowel, or lung transplant * Pancreas transplant less than 6 months ago * Cancer or any condition that would change weight dramatically in the near future such as malabsorption. * Willing to return for testing annually for 3 years * Women who are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Carotid Intima Media Thickness (CIMT)3 years (baseline and three year follow up)CIMT was defined by ultrasound. The mean and standard error of a 3 year change in CIMT was assessed (between baseline and three year follow up).

Countries

United States

Participant flow

Participants by arm

ArmCount
Kidney Transplant Recipients
This observational study evaluated nontraditional risk factors for their contributions to vascular disease progression as determined by carotid intima media thickness and history of vascular disease events over time. The study requires annual checks of blood, urine, history, and carotid ultrasound for carotid intima media thickness.
338
Total338

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath23
Overall StudyLost to Follow-up3
Overall Studyrelocation3
Overall Studytoo much time commitment1
Overall Studytransfer care to other clinical site1
Overall StudyWithdrawal by Subject39

Baseline characteristics

CharacteristicKidney Transplant Recipients
Age, Continuous52.3 years
STANDARD_DEVIATION 11
Ethnicity (NIH/OMB)
Hispanic or Latino
13 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
325 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
5 Participants
Race (NIH/OMB)
Black or African American
31 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
300 Participants
Sex: Female, Male
Female
147 Participants
Sex: Female, Male
Male
191 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
23 / 338
other
Total, other adverse events
0 / 338
serious
Total, serious adverse events
0 / 338

Outcome results

Primary

Carotid Intima Media Thickness (CIMT)

CIMT was defined by ultrasound. The mean and standard error of a 3 year change in CIMT was assessed (between baseline and three year follow up).

Time frame: 3 years (baseline and three year follow up)

Population: 264 participants had 3 year follow-up for Carotid intima media thickness.

ArmMeasureValue (MEAN)Dispersion
Kidney Transplant RecipientsCarotid Intima Media Thickness (CIMT)0.044 millimeters (mm)Standard Error 0.006

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026